- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: ferrotran.
Displaying page 1 of 1.
EudraCT Number: 2018-004310-18 | Sponsor Protocol Number: SPL-01-001 | Start Date*: 2019-10-07 | |||||||||||
Sponsor Name:Saving Patients' Lives Medical B.V. | |||||||||||||
Full Title: A confirmatory, prospective, open-label, single-arm, reader-blinded multi-centre phase 3 study to assess the diagnostic accuracy of Ferumoxtran-10-enhanced Magnetic Resonance Imaging (MRI) and unen... | |||||||||||||
Medical condition: newly-diagnosed prostate cancer (PCA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Prematurely Ended) BE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2023-000068-80 | Sponsor Protocol Number: ABR83709 | Start Date*: 2023-07-12 |
Sponsor Name:Radboud University Medical Center | ||
Full Title: Unravelling the invisible infiltrating component of glioblastoma using MRI and a strong iron-like bloodpool contrast medium? | ||
Medical condition: Detection of extent of tumor infiltration in healty brain tissue in patients with glioblastoma using USPIO as a blood pool contrast agent. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001869-32 | Sponsor Protocol Number: 24042019 | Start Date*: 2020-01-29 |
Sponsor Name:Radboudumc | ||
Full Title: Nano-MRI to visualize pancreatic inflammation in individuals with recent-onset type 1 diabetes | ||
Medical condition: Type 1 Diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000827-11 | Sponsor Protocol Number: T50/2021 | Start Date*: 2022-09-02 |
Sponsor Name:Turku University Hospital | ||
Full Title: Clinical use of USPIO contrast media in the assessment of pelvic lymph node metastasis in rectal cancer. | ||
Medical condition: Pelvic lymph node metastasis in rectal cancer. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
